Condition
Antiviral Drug
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 1 (1)
Trial Status
Unknown1
Enrolling By Invitation1
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07595458Phase 1RecruitingPrimary
Phase 1 Study on the Safety, Tolerability, and Pharmacokinetics of JST-018 in Healthy Adults
NCT04942886Not ApplicableEnrolling By Invitation
Prophylactic Entecavir for HBV Reactivation in Past HBV Infected Patients With Hematopoietic Stem Cell Transplantation
NCT03965286UnknownPrimary
Effect of Direct AntiViral Drugs of Chronic HCV on eGFR in Assuit Universiry Hospital
Showing all 3 trials